interleukin anti inflammatory cytokine limits immune responses foreign antigens blocking il time immunization increases cytotoxic cell responses antigen experienced host situation therapeutic vaccination cancer chronic viral infection patients develop ineffective immune responses tumour viral antigens immunotherapy starts graphene oxide nano material drug delivery tissue engineering current paper demonstrated absorb anti il receptor antibodies anti il antibodies absorbed slowly released release absorbed antibodies ph dependent absorbed anti il antibodies bioactive vitro vivo absorbed anti il antibodies efficient free anti il antibodies eliciting lps stimulated cd cell responses absorb anti il antibodies absorbed anti il antibody adjuvant vaccination ideal delivering tumour site breaking suppressive tumour environment 